Gynecology: Ovarian Cancer Clinic
The clinic's address is:
Obstetrics & Gynecology at Von Voigtlander Women's Hospital
1540 East Hospital Drive
Floor 9, Reception B
Ann Arbor, MI 48109
Dr. Mark Pearlman is an obstetrician/gynecologist who specializes in the gynecological care of breast cancer survivors, women with BRCA and other breast/gynecological cancer gene mutations and breast diseases. Breast cancer survivors can have unique gynecological needs and may experience gynecological complications of their breast cancer care. Management of menopause, complications or side effects from hormonal adjuvant therapies, such as tamoxifen and aromatase inhibitors (anastrozole or Arimidex™, letrozole or Femara™, exemestane or Aromasin™) are common.
Women with mutations in the BRCA1 or BRCA2 and other cancer genes (e.g., PALB2, RAD51C, RAD51D, CHEK2, etc.) face substantially increased risk of developing breast cancer and/or gynecological cancers in their lifetime. Working closely with the Breast and Ovarian Cancer Risk Evaluation Clinic, Dr. Pearlman offers management, monitoring and follow-up care for those who test positive for these different breast and gynecological cancer gene mutations. Amongst the management options to reduce cancer risk includes minimally invasive surgery (laparoscopy) to remove tubes and ovaries (bilateral salpingo-oophorectomy).
Dr. Pearlman is part of a multidisciplinary team including medical oncologists, surgical oncologists and plastic reconstructive surgeons with specific expertise in breast cancer and BRCA and other gene mutation management. In addition to being an exceptionally experienced gynecologic surgeon, Dr. Pearlman performs breast procedures when needed, such as fine needle aspirations, core biopsies and excisional breast biopsies.